Cofactor Genomics

Cofactor Genomics is a biotechnology company specializing in RNA sequencing technology to enhance predictive diagnostics, particularly in the field of immunotherapy for cancer treatment. The company has developed an innovative diagnostic tool known as the OncoPrism assay, which is designed to accurately predict how patients will respond to immunotherapy based on analyses of pre-treatment tumor biopsies. This approach represents a significant advancement over traditional methods, as it utilizes multidimensional biomarkers instead of relying on single analyte biomarkers, thereby providing a more…